Sarah Jordan

Sarah Jordan is a partner in Goodwin’s Antitrust and Competition practice. Dual qualified to practice in both England & Wales and Belgium, Sarah has a broad range of experience advising on European and UK, competition law matters, including EU, UK and international merger control and foreign investment matters, antitrust counselling, cartels and compliance.

Sarah is recognized as a leading lawyer in The Legal 500 UK and Who’s Who Legal Global Elite.

Sarah’s experience includes work with sectors as diverse as pharmaceuticals, air transport, directory and internet services, basic manufacturing and construction materials, chemicals, brewing, digital storage products, financial services, and paper. Her representative experience includes advising:

• Silo AI in its acquisition by Advanced Micro Devices, Inc
• Endomagnetics in its acquisition by Hologic, Inc. 
• Deciphera Pharmaceuticals in its $2.4 billion acquisition by ONO Pharmaceutical
• iRobot Corporation in its $1.7 billion proposed acquisition by Amazon.com, Inc.
• Thoma Bravo and its portfolio company Flexera in the acquisition of IT asset management firm Snow Software
• A leading company in the fashion industry in multi-jurisdictional cartel investigation
• Renesas Electronics Corporation in its acquisition of Sequans Communications
• Tata Communications in its acquisition of Kaleyra
• Pulsic in its acquisition by Cadence
• ReViral in its $525 million acquisition by Pfizer, Inc. 
• TCR² Therapeutics in its acquisition by Adaptimmune Therapeutics
• Forma Therapeutics on its $1.1 billion sale to Novo Nordisk
• Ritchie Bros. Auctioneers in its $7.3 billion acquisition of IAA, Inc. 
• Citrix Systems in its $16.5 billion sale to Vista Equity Partners and Evergreen Coast Capital
• Biocon Biologics Ltd. in its $3.335 billion agreement to acquire Viatris Inc.’s global biosimilars business
• Mimecast Limited in its $5.8 billion acquisition by Permira 
• GTCR and Corza Health, Inc., on the acquisition of TachoSil® Fibrin Sealant Patch from Takeda*
• A bidding consortium led by Advent, Cinven and the RAG-Stiftung on the acquisition of the elevator division of thyssenkrupp AG*
• Avaya Holdings Corp. on a strategic partnership with RingCentral, Inc*
• Advanced, a portfolio company of BC Partners and Vista Equity Partners, on its acquisition of legal technology business Tikit Limited from BT*
• Valeo Foods on its acquisition of Tangerine Confectionery*
• Accuride Corporation, a portfolio company of Crestview Partners, in connection with the acquisition of mefro wheels*
• Creat Group Corporation on its acquisition of Biotest AG*
• Vista Equity Partners in its $1.6 billion acquisition of Infoblox Inc*
• Vista Equity Partners on the $1.65 billion acquisition of Cvent, Inc*
• Tomkins Plc before the European Commission, and in connection with annulment proceedings before the European General Court and Court of Justice *
• Lafarge in connection with the creation of a joint venture comprising Lafarge and Anglo American (Tarmac)’s UK construction materials businesses*
• United Airlines on its merger with Continental*
• Schering-Plough on its US$41 billion merger with Merck*
• The Greek government on the State aid aspects of the restructuring and privatization of Olympic Airlines and Olympic Airways Services*
• Schering-Plough on its acquisition of Organon BioSciences*

*Denotes experience prior to joining Goodwin.

Prior to joining Goodwin, Sarah was most recently a partner at Kirkland & Ellis International LLP in London.

Sarah is a committee member and past chair of The Competition Section, Law Society of England and Wales. She is also a member of the American Bar Association, Antitrust Section.

Sarah is recognized for her work in The Legal 500 UK 2024 as a Leading Individual in EU and Competition law. She is also recognized in ‘Competition - Global Elite Thought Leader’ (2022-2023) by Who’s Who Legal and describes her as “Sarah is very well known in the market, and is particularly good on deals”.

Sarah was identified as a ‘Rising Star’ (2014) by Law360.

Sarah's publications include:

• Co-Author, “European Commission's First-Ever Abuse of Dominance Probe for shelving of a Novel Pipeline Therapy,” Goodwin Client Alert, April 24, 2024
• Co-Author, “Antitrust & Competition Technology 2023 Year in Review,” Goodwin Insights, March 25, 2024
• Co-Author, “Antitrust & Competition Technology 2022 Year in Review,” Goodwin Insights, February 21, 2023
• Co-Author, “EU Antitrust vs. U.S. Companies,” Law360, February 4, 2016

Her speaking engagements include:

• Speaker, "Antitrust: Implications for M&A and JVs," GCR Live 6th Annual Antitrust Law Leaders Forum, Miami, February 2017
• Speaker, "Compliance Workshop," IBC Legal, Advanced EU Competition Law Conference, Brussels, November 2016